Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis

PLoS ONE

Volumn 3, Issue 6, 2008, Pages

  Beer, Shelly ^a   Komatsubara, Kimberly ^a   Bellovin, David I ^a   Kurobe, Masashi ^a   Sylvester, Karl ^a   Felsher, Dean W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; CARBON TETRACHLORIDE; CARCINOGEN; CYCLIN B1; MYC PROTEIN; 5 DIETHOXYCARBONYL 1,4 DIHYDROCOLLIDINE; 5-DIETHOXYCARBONYL-1,4-DIHYDROCOLLIDINE; PRIMER DNA; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE OVEREXPRESSION; HISTOPATHOLOGY; HOST CELL; LATENT PERIOD; LIVER CARCINOGENESIS; LIVER CELL; LIVER TOXICITY; LIVER TUMOR; MOUSE; NEWBORN; NONHUMAN; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

MURINAE; MUS; MUS MUSCULUS;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CARBON TETRACHLORIDE; CARCINOGENS; DICARBETHOXYDIHYDROCOLLIDINE; DNA PRIMERS; GENES, MYC; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; PYRIDINES;

EID: 49449094901     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002493     Document Type: Article

References (47)

1. Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19: 1-11.
2. Felsher DW, Bishop JM (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4: 199-207.
3. Grandori C, Cowley SM, James LP, Eisenman RN (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16: 653-699.
4. Oster SK, Ho CS, Soucie EL, Penn LZ (2002) The myc oncogene: MarvelouslY Complex. Adv Cancer Res 84: 81-154.
5. Pelengaris S, Khan M, Evan G (2002) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2: 764-776.
6. Yaswen P, Goyette M, Shank PR, Fausto N (1985) Expression of c-Ki-ras, c-Haras, and c-myc in specific cell types during hepatocarcinogenesis. Mol Cell Biol 5: 780-786.
7. Nagy P, Evarts RP, Marsden E, Roach J, Thorgeirsson SS (1988) Cellular distribution of c-myc transcripts during chemical hepatocarcinogenesis in rats. Cancer Res 48: 5522-5527.
8. Chandar N, Lombardi B, Locker J (1989) c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet. Proc Natl Acad Sci U S A 86: 2703-2707.
9. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL (1989) Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4: 715-724.
10. Perraud F, Dalemans W, Gendrault JL, Dreyer D, Ali-Hadji D, et al. (1991) Characterization of trans-immortalized hepatic cell lines established from transgenic mice. Exp Cell Res 195: 59-65.
11. Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, et al. (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 53: 1719-1723.
12. Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS (1996) Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Am J Pathol 149: 407-428.
13. Santoni-Rugiu E, Jensen MR, Thorgeirsson SS (1998) Disruption of the pRb/ E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res 58: 123-134.
14. Reuber MD, Glover EL (1968) Carbon tetrachloride induced cirrhosis. Effect of age and sex. Arch Pathol 85: 275-279.
15. Grasso P, Sharratt M, Cohen AJ (1991) Role of persistent, non-genotoxic tissue damage in rodent cancer and relevance to humans. Annu Rev Pharmacol Toxicol 31: 253-287.
16. MacSween RN, Scott AR (1973) Hepatic cirrhosis: a clinico-pathological review of 520 cases. J Clin Pathol 26: 936-942.
17. Sell S, Hunt JM, Dunsford HA, Chisari FV (1991) Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res 51: 1270-1285.
18. Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS (1996) Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 15: 261-269.
19. Takagi H, Sharp R, Takayama H, Anver MR, Ward JM, et al. (1993) Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. Cancer Res 53: 4329-4336.
20. Bralet MP, Pichard V, Ferry N (2002) Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats. Hepatology 36: 623-630.
21. Dunsford HA, Karnasuta C, Hunt JM, Sell S (1989) Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies. Cancer Res 49: 4894-4900.
22. Farber E, Solt D, Cameron R, Laishes B, Ogawa K, et al. (1977) Newer insights into the pathogenesis of liver cancer. Am J Pathol 89: 477-482.
23. Evarts RP, Nagy P, Marsden E, Thorgeirsson SS (1987) A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 8: 1737-1740.
24. Sell S, Dunsford HA (1989) Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 134: 1347-1363.
25. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, et al. (2004) MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431: 1112-1117.
26. Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, et al. (2004) Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol 2: e332.
27. Farber JL, El-Mofty SK (1975) The biochemical pathology of liver cell necrosis. Am J Pathol 81: 237-250.
28. Rechnagel RO, Glende EA Jr (1973) Carbon tetrachloride hepatotoxicity: an example of lethal cleavage. CRC Crit Rev Toxicol 2: 263-297.
29. Preisegger KH, Factor VM, Fuchsbichler A, Stumptner C, Denk H, et al. (1999) Atypical ductular proliferation and its inhibition by transforming growth factor beta 1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest 79: 103-109.
30. Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukai K, et al. (2002) Bile acid-induced Mallory body formation in drug-primed mouse liver. Am J Pathol 161: 2019-2026.
31. Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, et al. (2003) The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A 100 Suppl 1: 11881-11888.
32. Engelhardt NV, Factor VM, Yasova AK, Poltoranina VS, Baranov VN, et al. (1990) Common antigens of mouse oval and biliary epithelial cells. Expression on newly formed hepatocytes. Differentiation 45: 29-37.
33. Obaya AJ, Mateyak MK, Sedivy JM (1999) Mysterious liaisons: the relationship between c-Myc and the cell cycle. Oncogene 18: 2934-2941.
34. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, et al. (2000) Identification of CDK4 as a target of c-MYC. Proc Natl Acad Sci U S A 97: 2229-2234.
35. Menssen A, Hermeking H (2002) Characterization of the c-MYC-regulated ranscriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A 99: 6274-6279.
36. Fausto N (1999) Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis 19: 243-252.
37. Sanders S, Thorgeirsson SS (2000) Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice. Mol Carcinog 28: 168-173.
38. Chang TH, Schlegel R (1996) SV40 T antigen increases the expression and activities of p34cdc2, cyclin A, and cyclin B prior to immortalization of human diploid fibroblasts. J Cell Biochem 60: 161-172.
39. Kaufmann WK, Levedakou EN, Grady HL, Paules RS, Stein GH (1995) Attenuation of G2 checkpoint function precedes human cell immortalization. Cancer Res 55: 7-11.
40. Wagner VO, 3rd, Blevins RD (1993) Chemically-induced histone modification as a predictor of carcinogenicity. Arch Environ Contam Toxicol 25: 260-266.
41. Yin XV, Grove L, Datta NS, Katula K, Long MW, et al. (2001) Inverse regulation of cyclin B1 by c-Myc and p53 and induction of tetraploidy by cyclin B1 overexpression. Cancer Res 61: 6487-6493.
42. Shiojiri N, Lemire JM, Fausto N (1991) Cell lineages and oval cell progenitors in rat liver development. Cancer Res 51: 2611-2620.
43. Nagy P, Bisgaard HC, Thorgeirsson SS (1994) Expression of hepatic transcription factors during liver development and oval cell differentiation. J Cell Biol 126: 223-233.
44. Bruccoleri A, Gallucci R, Germolec DR, Blackshear P, Simeonova P, et al. (1997) Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 25: 133-141.
45. Edwards MJ, Keller BJ, Kauffman FC, Thurman RG (1993) The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol Appl Pharmacol 119: 275-279.
46. Yamada Y, Fausto N (1998) Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 152: 1577-1589.
47. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 93: 10933-10938.